Join mRNA vaccine leaders, developers and distinguished scientists in Europe, delivering breakthrough research, technologies & connecting global pharma, biotech and academia for high-level discussions on the latest innovations within the nucleotide-based platforms for infectious diseases, novel immunotherapy approaches as oligonucleotide-based therapeutics
An intensive 2-day in person meeting that delves into the latest in mRNA vaccine research, platform technologies, novel immunotherapy strategies & clincial development case studies & a meeting place for experts working within oligo chemistry, therapeutics analytics and commercialisation. From new and exciting to the latest in products & services, our event will bring together leading companies for engaging discussions, knowledge sharing and focused networking.
The 2024 event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
Below were some of the key speakers of Vaccines Europe 2023
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of on-site experiences.